Member Info for extrader

Birth Name: William Henry Gates III. Place of Birth: Seattle, Washington, U.S. Date of Birth: October 28, 1955. Ethnicity: English, German, Scots-Irish/Northern Irish, Scottish.

That Irish mafia, I'm tellin' ya....

;->

.." ORPH in the Underwhelmed?.."

'ORPH 'n us in the underwhelmed', surely , Shirley ? '

;->

(1) Nominee account
https://www.hl.co.uk/online/share-account
.."Most shares these days are held digitally in what is known as a nominee account. Broadly, this means that the name of an individual does not appear on the share register of a company. Instead the name of the nominee company, which is holding the shares, does..."
In this case, Hargreaves Lansdowne, or other household name.
or
https://www.sharesoc.org/investor-academy/advanced-topics/nominee-accounts
29/07/2021 · If you hold shares in the nominee account of a stockbroker, you will not be on the share register and you are not a “Member” of the company. You are only the “Beneficial Owner” of the shares. The shares held on your behalf (and for other clients) by stockbrokers in a nominee account are typically “pooled” and there will be one entry in the register for all of them, in the stockbroker’s name i.e a household name.

(2) Nominee shareholder :
www.paramountformations.com/blog/nominee-sharehold…
.."Who is a nominee shareholder of a company?
They act as a legal, unrelated, third party, who is officially registered as the holder of shares on behalf of the actual shareholder. This shields the beneficiary owner from being publicly associated with that particular company..."

If you recognise the broker's name, it's likely to be (1), if it's 'Midas Holdings' or similar , it's likely to be (2)

.."They take a wage via the shares they award themselves with every year. Which they then sell on the open market. .."

FWLIW, AT has said in the past that he management team (including himself) don't sell these shares : they have other interests and/or resources.
His father Anthony John Trahar was CEO of AngloAmerican for 7 years (current MCap £ 35 billion) .

Oops ! Awful typo :

Totally agree comments re : Steve Thompson MBE - an inspirational story and the epitome of 'reliance', the theme for the Menphys charity event.....RESILIENCE.....that's RESILIENCE.....

Sorry, Steve !

Cont/......

POLB

Good presentation, essentially repeating what he said on Thursday.
Some snippets/ 'worth remembering':

- JS is 'emotionally intelligent' : picked up on the previous day's presentation criticism re lack of female representation on BoD and (partially) addressed it.

- nicely explained background to Poolbeg two stacks logo : like an old , repurposed power station , POLB would be looking to repurpose potential 'unwanted assets'.

- POLB (and ORPH) at a 'sweet spot' : how lucky (he didn't say 'of the Irish') to have acquired hVivo just before the pandemic ; and at a time when advances in AI are transformative for the pharma sector and POLB's business model;

- Infectious disease market spending : the 10x budget growth already mentioned; and the just announced US $ 65Bn spend includes grant-funding applications that POLB's target customers could access;

- pharma willingness to pay big money : they want strong IP; proven human safety; and something where a head start will kill the competition.

Referenced his co Inflazome : different business model [88% VC finance in 2016, MCap Euro 55M] sold 2020 for Euro 380m upfront + 'significant' downstream milestone payments : these would include 'payment by results' eg Ph 2 , Ph 3, and then - if commercialised' - ongoing royalties...
Roche were so keen they signed up on the strength of Ph 1 safety data and 1(one)patient 'proof of concept'.

- the PredictViral Biomarker Platform is of 'some interest' to the US military.

- the business model allows them to work with hVivo or not.

- strong IP for POLB-001 : EU patents granted, US pending.

- the USP of the HC data is not only range (300K samples) but also how comprehensive it is , esp as it includes Day-1 data : this means it can capture and identify severe disease much earlier (pre-symptomatic) .

Speedier diagnosis would be a 'category killer' : the current market leader, Tamiflu, only works at the early stages, if not diagnosed and stopped quickly enough, a 'cytokine storm' is pretty much inevitable.

Hope this covers it. Feedback/corrections welcome !

Apols if some of this is 'old news'.

E and OE, NAI, DYOR etc etc

My notes,
Totally agree comments re : Steve Thompson MBE - an inspirational story and the epitome of 'reliance', the theme for the Menphys charity event.

Hat tip to elrico and partners for making it possible. And for arranging a non-London centric event : there was a good 'local' turnout, although the winner of the 'furthest travelled' prize had come all the way up from the South coast....

'Respect' too, to CF and JS, for staying on for the entire Friday weekend evening (official end around 1130pm), rather than just do their own quick presentations and head for the door. Esp. as JS said (jokingly/ruefully) that he was a Leeds supporter and was missing Friday's big game against Newcastle...

ORPH

A somewhat more subdued CF than usual, taken to task by the very first Q re 'overpromise and under-deliver' , which he half-acknowledged and trotted out the 'perfect storm' defence, with the added distraction of POLB spin-off. This actually was a bit weak - if customers are lining up for ORPH services, the POLB side-show shouldn't interrupt contract flow (as it did for a while in H1).

Hard to know whether he's really chastened : several times made a point of saying 'in the next couple of months, errr, I mean over the coming months..'

Re H1 results, it sounds like they're going to be a bit curates-eggish :

- 'not quite as much as we'd hoped';

- CHIMs : Alpha characterisation Ph 1 now 'done', started on Delta, CHIM contracts will run into next year (well, doh !).

To be fair, CF said that part of the study start delay was the need to get what he called 'manslaughter insurance', which eventually had to be backstopped by HMG.

I can imagine pursed Civil Service lips at that one ;-<
CF pointed out that once there's a precedent [and the benefits seen] the resistance/delays should reduce.

The [likely underwhelming] RNS may be tempered by news of a new contract around the £ 8m mark.

The 'target' is for avge £ 5-6 m every month going forward.

Said revenue mix for 2022 was likely to be 30/70 Covid:nonCovid [does this square with others' understanding ? or is this the reality of delayed CHIM revenue recognition]

- DIM : 'near or around Xmas', we're trying to grow substantially...Having done the spadework on POLB, incl HMG tax negotiations, it should be easier / quicker to replicate.

- Imutex : 'nearly there ' then - after the familiar complaint re slowness - said something about 'going into public....[inaudible]'. Any ideas ?

- PrepBio : 'looking at small Nasdaq'.

- POLB : someone asked about the end of the lockup period and how to avoid a potential dump of sales cratering the share price?

CF first said that 9 months - 'up to '- seemed a reasonable balance; and then that -depending on business progress -if good, a sell-off would be less likely - possible permutations of 'phased release'; 'tender offer' to allow in a big investor; and/or progression to Nasdaq were all on the table.

Continued...

Gotham, what part of 'I have no economic interest' don't you understand ?

Some comments are at least 'interesting...but irrelevant'.

Yours aren't even interesting.

.." opinion on where you see the SP over next few weeks and months?"

No idea. I don't think (on the info currently available) that IM will work as was originally projected, OTOH a pivot to TF might (again, on the info currently available) .

BTW, as I've said before, I have no economic interest either way......and am not 'in cahoots' with anyone else.

.."I only stated facts Pat from the RNS...'

Your 0913 :
Some one gets a loan today to buy 10% of a bank???
Yesterday was the last day of the Arc vwap.

And I'm not Pat.

You've heard the saying 'Better to keep quiet - and be thought a fool - than to open your mouth and remove all doubt '?
You take it a stage further and provide evidence in writing.

ZIOC has to release its H1 2021 report by the 30th Sept., this should also include some kind of update re post H1 developments, if any.

Could be !
You're speculating on one interpretation, Gotham in another.
I only stated the facts.

Well, it would give a second reason (after Negma) to explain the recent s/price weakness.
So you should welcome it.

That tells you the qualifying period for establishing the warrant price.
It doesn't tell you when the loan is available (and drawn).
Think about it : SYME is issuing warrants as a 'reward' for getting the cash, it'll want to know it's got the cash first.
A cynic might observe that it's in the family office interest to see the reference price lower....

Not necessarily.

The 10 days you refer to is linked to the reference period for pricing the warrants.
The RNS dated 2 Sept about the ARC-arranged loan said that a term sheet had been agreed and that the loan was subject to the execution of the definitive agreement.
Maybe the loan HAS been provided, maybe not.

If the current weather patterns continue to winter - and the current outage of French supply is genuinely technical (and not linked to the Aussie subs 'snub') - there's a good chance we'll be firing up our coal stations later this year, IMO.

Coming just after Glasgow COP and the current 'push to green' that'll put HMG in an 'interesting' position...

Well, on the offchance they might reply, I thought it was worth dropping a line to Larsen and Toubro, the Indian MozMal transmission contracts winners.

I congratulated them on the award and asked who they expected would be generating in 4 years' time the electricity that their connections are intended to deliver...and to whom ?

'Fragen kostet nichts' as the Germans have it : it costs nothing to ask.

From past communications, I believe this message - posted on a d v f n - to be genuine.

".....SRTCEO15 Sep '21 - 09:05 - 11020 of 11020
0 5 0
Good morning.
As you will be aware, I do not partake in this discussion on SRT.

The reason for this post is to clarify some concerns that have been raised in the last 24hrs in regards to our AGM and Investor open day. To save another clarification RNS I concluded this was the most effective method.

1) Anyone and everyone is invited to the investor open day: 9:00am to 11:00am at our MSN offices. Attending on SRT side will be all senior managers to discuss and answer all and any questions. There will also be a live GeoVS system with an SRT operator to show anyone interested all the various functionalities. This is an opportunity to speak to everyone and anyone in the company and ask what you want.

2) The AGM and shareholder update presentation which starts from 11am, will be filmed and streamed live to a web portal where those not attending can watch and text in questions - as we have stated in the RNS the identities of those watching are not public and only me and the board will see the questions sent in on a tablet. For the avoidance of doubt the earlier investor open day bit will NOT be filmed and is held in a separate room to the AGM.

3) Nobody but me and SRT board members will be filmed and the micro-phones are directional and localised next to us and thus will not pick up the voices of people there asking questions. When a question is asked, I will repeat it for the benefit of those viewing remotely. As such anyone attending is completely assured of their privacy.

I hope that the above clarifies these concerns. We at SRT are looking forward to meeting everyone again and discussing our business, the progress its made, the challenges we have and of course the status of the long awaited nearest contracts in Middle East and SE Asia, as well as all the real opportunities that define our VSP. For me I hope its an opportunity for anyone to ask blunt and frank questions to the entire team and hopefully come away much more positive than when arriving with a deeper understanding of the business. And, of course, irrespective of this opportunity anyone is always welcome to telephone the office or email me or any of the directors directly with questions.

I will take this opportunity to thank you all for your robust debate on our prospects within the global maritime domain awareness market - even though at times, as you would expect, I feel some of the conclusions are not right.

Kind regards
Simon.... "

HTH, NAI, DYOR etc etc

In the interest of balance, it looks as though there may be alternatives further down the road :
- from Moz's gas resources (when these become available), although the grid would need to be reworked; and
- https://clubofmozambique.com/news/mozambique-to-sell-majority-stake-in-2-4bn-hydropower-dam-bloomberg-195089/
although Financial Close isn't expected until 2025 and construction would take another 5 years or so - if CB is any guide.

.."Mphanda Nkuwa will be about 60 kilometres (37 miles) downstream the Zambezi River from the Cahora Bassa hydropower dam that has the capacity to generate 2,075 megawatts of power. Mozambique sells most of the electricity from that dam to neighbouring South Africa, where there have been shortages for more than a decade..."

Ho hum.

Point taken. However,

https://clubofmozambique.com/news/mozambique-ncondezi-signs-epc-contract-for-coal-fired-power-plant-with-china-machinery-engineering-200760/

- my understanding was that most CB hydro went to S Africa, which has increasing supply problems of its own;
- CB reliability/availability was variable, as - ironically - climate change is blamed for rainfall shortfall and water levels;
- use of the new transmission lines to increase demand for CB downstream to the East (Mozambique) and new market (Malawi) would be 'doubling down' and seems counter-intuitive, to say the least...especially for Mozambique, with its own power supply ambitions;
- the graphic suggests strongly - "But it would ... wouldn't it ?" ;-> - that a power station at Tete addresses a number of these issues.

AIUI